Objective:

The article examines the objective, findings, and clinical context described in Prula-cel Shows Early Promise in Lupus.

Approach:

• Study population: The efficacy dataset included 22 patients: 16 with lupus nephritis and six with extra-renal SLE. All had at least six months of follow-up; 13 had at least 12 months.
• Treatment: Prula-cel is an investigational, off-the-shelf allogeneic gamma delta CAR T therapy targeting B cells through an anti-CD20 CAR.

Key Findings:

• At 12 months, 54% of evaluable patients achieved DORIS remission; 50% of evaluable lupus nephritis patients achieved complete renal response.
• All patients discontinued immunosuppressants, and all but one reduced corticosteroids to 5 mg or less of prednisone equivalent daily.
• The company reported that 12-month responses were generally maintained through 12–21 months of follow-up.
• Among 24 safety-evaluable patients, 25% had Grade 1 or 2 cytokine release syndrome; none had CRS above Grade 2, neurotoxicity, IEC-HS, graft-versus-host disease, or dose-limiting toxicities.
• Infections occurred in 54% of patients, including Grade 3 or higher infections in 8.3%.
• All 22 efficacy-evaluable patients had undetectable CD19-positive B cells followed by naïve-dominant B-cell reconstitution.

Interpretation:

Adicet Bio described the B-cell findings as evidence of an “immune reset.” The reported results are from a Phase I dataset.

Limitations:

• The efficacy-evaluable population was small (22 patients), and only 13 had at least 12 months of follow-up.
• The context provides no comparator group or detailed study methods.
• The findings are company-reported; no publication or source URL was provided.

Conclusion:

Adicet plans a single-arm pivotal study in lupus nephritis patients who responded inadequately to at least two immunosuppressants, with start-up activities expected in the fourth quarter of 2026. The company also plans to discuss potentially including patients with SLE without nephritis.

Sources:

• Article context supplied in the prompt